Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
Enabling Successful Sites, Episode 5: Strategies for improving communication between sites, sponsors and CROs
|
Feb 24, 2025 |
|
Is there room for new COAs in neuroscience?
|
Feb 24, 2025 |
|
Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention
|
Jan 06, 2025 |
|
Enabling Successful Sites: Episode 4, Part One: Partnering with sites to improve patient recruitment and retention
|
Jan 06, 2025 |
|
Leveraging people, processes and technology to deliver for biotech
|
Dec 06, 2024 |
|
Navigating market access in neuroscience: Challenges and strategies
|
Oct 16, 2024 |
|
Leveraging people, processes and technology to deliver for biotech
|
Oct 01, 2024 |
|
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
|
Sep 25, 2024 |
|
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval
|
Sep 25, 2024 |
|
Podcast: Accelerated approvals – what’s next, confirmatory trials, access, and pricing
|
Aug 05, 2024 |
|
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept
|
Jul 16, 2024 |
|
Enabling Successful Sites Ep. 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
|
Jun 28, 2024 |
|
Enabling Successful Sites Ep. 3: Taking the complexity out of oncology trials
|
Jun 28, 2024 |
|
De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works
|
Jun 19, 2024 |
|
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
|
May 23, 2024 |
|
Enabling Successful Sites, Episode 1: Solving Site Feasibility and Start-Up Challenges
|
May 10, 2024 |
|
Rare Endpoints: Delivering on Unmet Patient Needs
|
May 07, 2024 |
|
Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 3
|
Apr 25, 2024 |
|
Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 2
|
Apr 25, 2024 |
|
Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1
|
Apr 25, 2024 |
|
CAR-T boxed warnings: What comes next?
|
Mar 06, 2024 |
|
Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements
|
Jan 10, 2024 |
|
Three trends impacting market access in the EU
|
Jan 04, 2024 |
|
How can we advance fair and ethical reimbursement for patients?
|
Nov 21, 2023 |
|
Beyond the Binary: Navigating Gender Diversity in Clinical Research
|
Jun 08, 2023 |
|
Why Rare Disease Therapeutics Need Early Market Access Planning
|
Jan 03, 2023 |
|
CROs and Their Role for Nano-rare
|
Jan 03, 2023 |
|
RBQM Podcast Series | Episode 4: Three ways to de-risk your DCT implementation
|
Dec 05, 2022 |
|
Careers at Parexel — FSP Podcast Series | Episode 2: Celebrating a 25-Year Career with Kerri McCaul-Claus
|
Dec 05, 2022 |
|
Careers at Parexel — FSP Podcast Series | Episode 1: Get Recruited to Be a Clinical Research Associate: The Benefits of Parexel’s FSP Program
|
Oct 26, 2022 |
|
The Parexel Podcast | Episode 20: Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
|
Sep 19, 2022 |
|
Decentrally Speaking | Episode 3: Integrating the Patient Voice into Decentralized Trials
|
Jul 28, 2022 |
|
RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry
|
Jun 20, 2022 |
|
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
|
May 09, 2022 |
|
RBQM Podcast Series | Episode 2: Cultivating Risk-based Behaviors
|
Mar 23, 2022 |
|
Decentrally Speaking, a Parexel Podcast | Episode 1: Optimizing Trial Inclusivity For Patients From Under-Represented Communities
|
Mar 21, 2022 |
|
Episode 19: Improving Rare Disease Drug Development
|
Feb 28, 2022 |
|
RBQM Podcast Series | Episode 1: Getting it Right Upfront - Managing Study Risk from End-to-End
|
Feb 25, 2022 |
|
Episode 17: Funding Biotech Innovation: How to Attract Investors
|
Jan 18, 2022 |
|
Episode 16: COVID-19 Vaccines and Kids: The Research and Vaccine Explained
|
Nov 18, 2021 |
|
Episode 15: Pandemic Preparedness: Investing in the future of infectious disease vaccine development
|
Feb 08, 2021 |
|
Episode 14: Why Parents and Children Join Research Studies: CISCRP’s 2020 Pediatric Perceptions & Insights Survey Reveals Critical Insights
|
Dec 08, 2020 |
|
Episode 13: The New Pragmatism: Clinical Trials, Investment and Regulations Post-COVID-19
|
Jul 30, 2020 |
|
Episode 12: ASCO20 Debrief: The latest in cell and gene therapy
|
Jun 05, 2020 |
|
Episode 11: Maintaining Clinical Trial Continuity During COVID-19: The Patient Perspective
|
May 19, 2020 |
|
Episode 10: The emerging role of wearables in clinical trials
|
May 15, 2020 |
|
Episode 9: Making the Most of Functional Service Provider (FSP) Relationships
|
May 07, 2020 |
|
Episode 8: Performing clinical trials in a shifting development landscape
|
Apr 08, 2020 |
|
Episode 7: International Women’s Day: Insights from Ascending Davos
|
Mar 06, 2020 |
|
Episode 6: The opportunity for biotechs in precision medicine: driving value and bringing important new therapies to patients
|
Mar 04, 2020 |
|
Episode 5: CAR-T: How far have we come and where are we going?
|
Feb 27, 2020 |
|
Episode 3: Bridging the Gap – How Minimizing Patient Barriers Can Improve Clinical Research
|
Aug 19, 2019 |
|
Episode 2: Tackling Rare Diseases & Inside the FDA
|
Apr 24, 2019 |
|
Episode 1: International Women's Day
|
Mar 06, 2019 |